Zobrazeno 1 - 6
of 6
pro vyhledávání: '"劉益昌"'
Autor:
Hui-Hua Hsiao, Yi-Chang Liu, Hui-Jen Tsai, Jui-Feng Hsu, Wen-Chi Yang, Chao-Sung Chang, Sheng-Fung Lin, 蕭惠樺, 劉益昌, 蔡慧珍, 許瑞峰, 楊文祺, 張肇松, 林勝豐
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 27, Iss 2, Pp 49-54 (2011)
The Philadelphia (Ph) chromosome and/or Breakpoint cluster region-Abelson leukemia virus oncogene transcript are unique markers for chronic myeloid leukemia (CML). However, CML demonstrates heterogeneous presentations and outcomes. We analyzed the cy
Externí odkaz:
https://doaj.org/article/3437dc2609074b7ab32e2c906972690b
Autor:
Hsiao, Hui-Hua, Liu, Yi-Chang, Tsai, Hui-Jen, Hsu, Jui-Feng, Yang, Wen-Chi, Chang, Chao-Sung, Lin, Sheng-Fung, 蕭惠樺, 劉益昌, 蔡慧珍, 許瑞峰, 楊文祺, 張肇松, 林勝豐
Publikováno v:
In Kaohsiung Journal of Medical Sciences 2011 27(2):49-54
Autor:
Yi-Chang Liu, 劉益昌
101
Hematologic malignancies comprise a group of heterogeneous diseases. There have been marked progresses in explorating the roles of host factors in pathogenesis and developing novel therapeutic interventions. Host genetic and environmental ex
Hematologic malignancies comprise a group of heterogeneous diseases. There have been marked progresses in explorating the roles of host factors in pathogenesis and developing novel therapeutic interventions. Host genetic and environmental ex
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/60313409426093419141
Autor:
Yi-Chang Liu, 劉益昌
91
Imatinib mesylate, a potent inhibitor of the Bcr-Abl tyrosine kinase that is central to the pathogenesis of CML, has demonstrated remarkable hematologic and cytogenetic response especially in chronic phase. This was well documented in various
Imatinib mesylate, a potent inhibitor of the Bcr-Abl tyrosine kinase that is central to the pathogenesis of CML, has demonstrated remarkable hematologic and cytogenetic response especially in chronic phase. This was well documented in various
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/xda47d